NFKB1 and cancer: Elevated NF-κB activation maintains the production of cytokines and chemokines that are strongly associated with cancer progression, recurrence, and chemoresistance [11–14], and thus endogenous upstream stimulators in cancer cells need to be managed to control persistent NF-κB-linked events in EOC.